Need Help? Call 1­-866-­796-­7386
« back to stock screener

  OBLN stock: Obalon Therapeutics Inc

Current Rating
Hold/Sell

Previous Rating

Hold/Sell
Our Strong Buys
double the S&P500!
Learn more.
Company Statistics
Price
$2.48
Market Cap
28.3M
Sector
Health Care
Div. Growth
-
P/E
-
P/B
4.95
P/S
14.53
Dividend %
-
P/CF
-
P/FCF
-
Op. Cash Flow
-10.4K
FCF
-1.4
Op. Margin
-751.90%
Net Margin
-776.70%
ROE
-171.10%
ROI
-234.40%
ROA
-88.60%
EPS Growth
78.30%
Current Ratio
1.6
Debt/Equity
8.50%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
AEterna Zentaris Inc. (USA) (AEZS) $0.91 - - 133.3M Strong Buy
RadNet Inc. (RDNT) $22.24 - - 1.14B Strong Buy
AngioDynamics, Inc. (ANGO) $23.93 - - 888.4M Strong Buy
Bristol-Myers Squibb Co (BMY) $65.60 - 3.10% 141.03B Strong Buy
Regulus Therapeutics Inc (RGLS) $1.23 - - 113.1M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More